Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol President Dolan Shares CEO Heimbold's Non-Rx Background

Executive Summary

Bristol-Myers Squibb President Peter Dolan is following the career trajectory model set by Chairman & CEO Charles Heimbold, who ascended to the top of Bristol management from a background predominantly outside the company's core pharmaceuticals business.
Advertisement

Related Content

SEC Hints At Further Charges In Bristol Case: Focus Shifts To Former Execs
SEC Hints At Further Charges In Bristol Case: Focus Shifts To Former Execs
Bristol Takes Stock: Hayden To Head U.S. Rx After Lane Departs
Bristol Takes Stock: Hayden To Head U.S. Rx After Lane Departs
Procter & Gamble Recants: Size Does Matter In Rx Industry
Bristol Worldwide Rx Head Hayden Is Among Candidates In Succession Race
Bristol Worldwide Rx Head Hayden Is Among Candidates In Succession Race
Advertisement
UsernamePublicRestriction

Register

PS035467

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel